Societe Generale Effekten (S28964) 시세

25,000 shares x $0.20 = $5,000 USD

Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o

https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?

2025-2027 will be TSLA years!

The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.

FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl

50,000 shares x $0.20 = $10,000 USD

100,000 shares x $0.20 = $20,000 USD

250,000 shares x $0.20 = $50,000 USD

$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.

500,000 shares x $0.20 = $100,000

Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an

TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di

Trump's pandemic killed 1.3 million Americans,  you must be so happy with his choice to downplay it.

1,000,000 shares x $0.20 = $200,000 USD

Cohen said $0.20 by May 2025! $ZHUD

$KRTL Another good day today. Thin share structure and going to move fast.

Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market

Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi

Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y

We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr

What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg

NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.